Limpar, Gerlyn V.

HRN: 27-03-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
CEFUROXIME 500MG (TAB)
06/23/2026
06/29/2026
PO
500mg
BID
SP Completion Curettage
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines